TUCATINIB | TUCATINIB | ATC L01EH03
ANTINEOPLASTIC A TYROSINE KINASE INHIBITOR OF HER2 TREATMENT OF BREAST CANCER | ORAL | Tmax 2 HOUR VD 1670 LITER PPB 97.1 PERCENT Cl 148 LITER / HOUR HT 8.5 HOUR | HER2 | ERBB2 INHIBITOR P04626 (ERBB2_HUMAN) | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |